Global biotherapeutics virus removal filters market demand is anticipated to be valued at USD 451.2 million in 2023. It is forecasted to thrive at a CAGR of 8.0% from 2023 to 2033, reaching a market valuation of USD 972.6 million by 2033.
Growth is attributed to the pre-determined risk of contamination in biotherapeutic products and technological advancement in healthcare. From 2018 to 2022, a CAGR of 5.8% was registered for this market.
| Attributes | Details |
|---|---|
| Biotherapeutics Virus Removal Filters Market Share (2022) | USD 424.3 million |
| Biotherapeutics Virus Removal Filters Market Share (2023) | USD 451.2 million |
| Biotherapeutics Virus Removal Filters Market Share (2033) | USD 972.6 million |
| Biotherapeutics Virus Removal Filters Market Share (2023 to 2033) | 8.0% |
The biotherapeutics virus removal filters can be used either in vivo or in-vitro environments. In biotherapeutics virus removal filtration, the virus removability is based on a size-exclusion mechanism that is those viruses that are superior to the mean pore size, became trapped.
The biotherapeutics virus removal filters are basically used during the manufacturing of biotherapeutic drug products or samples such as therapeutic replacement enzymes, antibodies, blood, derivatives of plasma, and biopharmaceuticals. The pre-determined risk of contamination in biotherapeutic products is the major factor that can upsurge the growth of the biotherapeutics virus removal filters market.
North America is expected to dominate the biotherapeutics virus removal filter market due to the advent of advanced technologies in this region. Overall, the global biotherapeutics virus removal filters market is expected to show significant growth over a forecast period.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Increasing awareness about the benefits of using biotherapeutics virus removal filters among healthcare professionals and consumers fuelling the demand for the biotherapeutics virus removal filters market.
Technological advancements in filter design and manufacturing improve performance, reduce costs, and increase efficiency will boost the growth of the market in the forecasting period. The rising incidence of infectious diseases and growing investments in healthcare infrastructure development provide lucrative opportunities to the market.
Although the biotherapeutics virus removal filters market has numerous end-uses, there are numerous obstacles that likely pose a challenge to market growth. Lack of technical expertise and lack of awareness may impede the growth of the biotherapeutics virus removal filter market.
North America was the largest market for the biotherapeutics virus removal filters market and the trend is expected to continue into the forecast period owing to the increasing number of research going on monoclonal antibodies (mAb) and recombinant protein, which require virus removal filters.
North America is expected to be the next dominant region witnessing high adoption rates for the biotherapeutics virus removal filters market during the forecast period.
The technological advancement in the healthcare sector in the region is expected to augment the biotherapeutics virus removal filter market. The region is forecasted to have a 33.2% share of the biotherapeutics virus removal filters market.
According to Future Market Insights Europe is expected to hold the second-largest market share in the global biotherapeutics virus removal filters market due to the advanced medical facilities and easy availability of the biotherapeutics virus removal filters in the market in the region.
Europe is predicted to account for a total 29.5% share in the global biotherapeutics virus removal filters market.
Increasing healthcare investments and the presence of prominent market vendors and providers also benefit Europe’s market. The global biotherapeutics virus removal filter market is gaining traction in the region due to increasing research facilities and the developing biopharmaceutical industry.
Some stringent government regulations in Germany and France in terms of approval, restrain the growth of this market in the European region.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Despite the threat of the COVID-19 pandemic having subsided, there is a lingering apprehension about contracting the infection through direct and indirect means. Hence, healthcare providers are making sure their facilities are properly sanitized and rendered germ-free.
This is the widening of the uptake of biotherapeutics virus removal filters to a large extent. Here are some notable start-ups operating within this domain.
| Company Name | Spry Therapeutics |
|---|---|
| Origin | United States |
| Year of Establishment | 2018 |
| Company Name | BioLife |
|---|---|
| Origin | Canada |
| Year of Establishment | 2004 |
| Company Name | MDI Membrane Technologies |
|---|---|
| Origin | United States |
| Year of Establishment | 2014 |
| Company Name | Flow Filters |
|---|---|
| Origin | Canada |
| Year of Establishment | 2007 |
| Company Name | Agentis Air |
|---|---|
| Origin | United States |
| Year of Establishment | 2019 |
| Company Name | FilterEasy |
|---|---|
| Origin | United States |
| Year of Establishment | 2012 |
| Company Name | Pacific Air Filtration |
|---|---|
| Origin | United States |
| Year of Establishment | 2014 |
Some of the key participants present in the global biotherapeutics virus removal filters market includes Pall Corporation, Z-Medica, LLC, Asahi Kasei Corporation, Merck KGaA, and Sartorius AG among others.
Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Pall Corporation, Z-Medica, LLC, and Asahi Kasei Corporation account for a considerable market size, several regional-level players are also operating across key growth regions, particularly in the Asia Pacific.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; Asia Pacific; Middle East & Africa (MEA) |
| Key Countries Covered | United States, Canada, Germany, United Kingdom, Nordic, Russia, BENELUX, Poland, France, Spain, Italy, Czech Republic, Hungary, Rest of EMEAI, Brazil, Peru, Argentina, Mexico, South Africa, Northern Africa, GCC Countries, China, Japan, South Korea, India, ASEAN, Thailand, Malaysia, Indonesia, Australia, New Zealand, Others |
| Key Segments Covered | Technology, Application, End-user, Region |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Trend Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The projected CAGR of the Biotherapeutics Virus removal filters Market by 2033 is 8%.
The projected market value for 2033 is USD 972.6 million.
The market is estimated to secure a valuation of USD 451.2 million in 2023.
The food and beverage industry are the key consumer of the Biotherapeutics Industry.
| Estimated Size, 2025 | USD 1,920.3 million |
|---|---|
| Projected Size, 2035 | USD 3,969.3 million |
| CAGR (2025 to 2035) | 7.5% |
| Market Value (2022) | USD 2,041 million |
|---|---|
| Market Forecast Value (2032) | USD 8,401.71 million |
| Market Expected CAGR (2022 to 2032) | 15.2% |
Explore Life Science & Biotechnology Insights
View Reports
Biotherapeutics Virus removal filters Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
